AzTrials
AzTrials

Liver Cirrhosis, BiliaryNCT04629456

Physical Therapy for Liver Cirrhosis

A study testing neuromuscular electric stimulation and Exercises in people with Liver Cirrhosis, Biliary, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients with liver cirrhosis have severe physical deconditioning. Aim: To compare between the effect of neuromuscular electric stimulation(NMES) and exercises (EX)on treatment of patients with liver cirrhosis. Read more about this study

Who is it for?
Ages 35 to 59 years
Conditions the study is for
Liver Cirrhosis, Biliary
What is being tested?
neuromuscular electric stimulation and Exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
7 Jan 2020to 5 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 59 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Positive for anti-HCV.
  • Not under antiviral therapy at entry.
  • Positive for chronic hepatitis or compensated cirrhosis.
  • Negative for hepatitis B surface (HBs) antigen.
  • Free of co-infection with HIV.
  • Not pregnant.
  • Systolic blood pressure of less than 180 mmHg or diastolic blood pressure of less than 110 mmHg.
  • (viii)No ischemic heart disease or severe arrhythmia

Who cannot join

  • Significant cardiac disease (ejection fraction <60% or history of coronary artery disease).
  • Chronic renal failure on dialysis.
  • Hemoglobin <11.0 g/L.
  • Human immunodeficiency virus infection.
  • Hepatocellular carcinoma.
  • Active non-hepatocellular carcinoma related malignancy.
  • Myopathy.
  • Any physical impairment or orthopedic abnormality preventing EX, or post-liver transplantation

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Manal K. youssef

    Cairo, 11528

Other trials in Egypt

About this study

Official title: Neuromuscular Electric Stimulation and Exercises Effect on Functional Exercise Performance and Quality of Life in Cases of Liver Cirrhosis

Patients with liver cirrhosis have severe physical deconditioning. Aim: To compare between the effect of neuromuscular electric stimulation(NMES) and exercises (EX)on treatment of patients with liver cirrhosis.

Read the detailed description

70 patients have been chosen from department of internal medicine, Cairo university hospitals, Egypt. 5 patients refused to participate .65 patients divided randomly into 2 groups. All the procedures were explained to patients.2 patients refused to sign informed consent and excluded from the study. 31 patients in group1 and 32 patients in group2. 1patients dropped in group1 and excluded from the study and two patients didn't continued the programmed treatment in group 2 and their data removed.

Thirty patients in each group signed an informed consent and complete the treatment program.

Being tested
neuromuscular electric stimulation, Exercises
Keywords
liver cirrhosis, exercises, neuromuscular electric stimulation, exercise capacity, quality of life
Medical subject headings
Liver Cirrhosis, Biliary, Liver Cirrhosis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neuromuscular electric stimulationOther

    A total of eight electrodes were placed on the quadriceps femoris muscles (four on each leg): two on the vastus medialis, one on the rectus femoris muscle, and one on the vastus lateralis muscle. The stimulation protocol of the NMES consisted of a symmetrical biphasic square pulse at 75 Hz, a duty cycle of 6 seconds (sec.) on and 29 sec. off, a pulse time of 410 sec. during a session lasting 20 min. The intensity was increased to maximum individual toleration. The muscle contractions were visible and palpable.

  • ExercisesOther

    The chair-seated exercises were used in the early stages of the program because the participants were frail adults. Repetitions of toe raises, heel raises, knee lifts, knee extensions, and others were performed while seated on a chair. Hip flexions, lateral leg raises, and repetitions of other exercises were performed standing upright behind the chair and holding the back of the chair for stability. To strengthen lower extremities, a fixed weight was placed on the ankle while participants performed strengthening exercises. Weights of 0.50, 0.75, 1.00, and 1.50 kg were used in accordance with each participant's strength level as the resistance progressively increased. The exercises performed using these ankle weights included seated knee flexion and extension and standing knee flexion and extensions. Exercises using a resistance band: Resistance bands were used to strengthen lower body. Lower body exercises included leg extension and hip flexion

Study groups in NCT04629456
Study groupRoleWhat they receive
group 1ExperimentalA total of eight electrodes were placed on the quadriceps femoris muscles (four on each leg): two on the vastus medialis, one on the rectus femoris muscle, and one on the vastus lateralis muscle. The stimulation protocol of the NMES consisted of a symmetrical biphasic square pulse at 75 Hz, a duty cycle of 6 seconds (sec.) on and 29 sec. off, a pulse time of 410 sec. during a session lasting 20 min. The intensity was increased to maximum individual toleration. The muscle contractions were visible and palpable.
Receives: Other: neuromuscular electric stimulation
Group 2ExperimentalThe chair-seated exercises were used in the early stages of the program because the participants were frail adults. Repetitions of toe raises, heel raises, knee lifts, knee extensions, and others were performed while seated on a chair. Hip flexions, lateral leg raises, and repetitions of other exercises were performed standing upright behind the chair and holding the back of the chair for stability. To strengthen lower extremities, a fixed weight was placed on the ankle while participants performed strengthening exercises. Weights of 0.50, 0.75, 1.00, and 1.50 kg were used in accordance with each participant's strength level as the resistance progressively increased. The exercises performed using these ankle weights included seated knee flexion and extension and standing knee flexion and extensions. Exercises using a resistance band: Resistance bands were used to strengthen lower body. Lower body exercises included leg extension and hip flexion(24).
Receives: Other: Exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sitting standing test

    number of cycle /30 seconds

    Measured: 12 week

  2. Balance

    Seconds

    Measured: 12 weeks

  3. Time up and go test

    number of cycle / minute

    Measured: 12 weeks

  4. 6 Minutes walk distance

    distance walked in 6 minutes

    Measured: 12 weeks

  5. 2 Minutes steps test

    number of steps in 2 minutes.

    Measured: 12 weeks

  6. Chronic liver diseases questionnaire (CLDQ)

    score

    Measured: 12 week

  7. SF-36

    Score

    Measured: 12 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2020
  2. Study start7 Jan 2020
  3. Primary completion12 May 2020
  4. Study completion5 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04629456
Sponsor's protocol ID
P.T. REC/012/002609
Status last verified
Nov 2020
First submitted
10 Nov 2020
Last updated
16 Nov 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data shared on reasonable request from corresponding author.

Questions about this trial

What is this clinical trial studying?

A study testing neuromuscular electric stimulation and Exercises in people with Liver Cirrhosis, Biliary, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sitting standing test (time frame: 12 week). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in